Suppr超能文献

新冠疫苗的上市速度与疫苗犹豫:一项横断面调查研究。

COVID-19 Vaccine's Speed to Market and Vaccine Hesitancy: A Cross-Sectional Survey Study.

机构信息

Research Analyst Department of Community Health Sciences Cumming School of Medicine University of Calgary Research Analyst O'Brien Institute for Public Health University of Calgary Calgary, AB.

Senior Research Associate Department of Community Health Sciences Cumming School of Medicine University of Calgary Senior Research Associate O'Brien Institute for Public Health University of Calgary Calgary, AB.

出版信息

Healthc Policy. 2023 Aug;19(1):99-113. doi: 10.12927/hcpol.2023.27153.

Abstract

BACKGROUND

This paper aims to assess the extent to which the COVID-19 vaccine's speed to market affected Canadian residents' decision to remain unvaccinated.

METHOD

A cross-sectional survey conducted in late 2021 asked participants whether they had received the vaccine and their reasons for abstaining.

RESULTS

Of the 2,712 participants who completed the survey, 8.9% remained unvaccinated. Unvaccinated respondents who selected "They made the vaccine too fast" (59.8%), were significantly more likely to identify as white, believe that the COVID-19 pandemic was not serious and have an unvaccinated social circle.

CONCLUSION

Should the COVID-19 vaccine rapid regulatory process be expanded, more patients may refuse treatment than if traditional timelines are followed.

摘要

背景

本文旨在评估 COVID-19 疫苗上市速度对加拿大居民未接种疫苗决定的影响程度。

方法

2021 年末进行的一项横断面调查询问了参与者是否接种了疫苗及其未接种的原因。

结果

在完成调查的 2712 名参与者中,8.9%的人未接种疫苗。选择“疫苗研发速度过快”的未接种受访者(59.8%),更有可能自认为是白人,认为 COVID-19 大流行并不严重,且社交圈中未接种疫苗的人较多。

结论

如果扩大 COVID-19 疫苗的快速监管程序,可能会有更多的患者拒绝治疗,而不是遵循传统的时间线。

相似文献

1
COVID-19 Vaccine's Speed to Market and Vaccine Hesitancy: A Cross-Sectional Survey Study.
Healthc Policy. 2023 Aug;19(1):99-113. doi: 10.12927/hcpol.2023.27153.
2
Assessment of Communication Strategies for Mitigating COVID-19 Vaccine-Specific Hesitancy in Canada.
JAMA Netw Open. 2021 Sep 1;4(9):e2126635. doi: 10.1001/jamanetworkopen.2021.26635.
3
Changes in COVID-19 vaccine hesitancy at different times among residents in Guangzhou, China.
Front Public Health. 2023 Jun 13;11:1164475. doi: 10.3389/fpubh.2023.1164475. eCollection 2023.
5
COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.
Vaccine. 2022 Oct 12;40(43):6271-6276. doi: 10.1016/j.vaccine.2022.08.070. Epub 2022 Sep 14.
7
COVID-19 Vaccine-Related Attitudes and Beliefs in Canada: National Cross-sectional Survey and Cluster Analysis.
JMIR Public Health Surveill. 2021 Dec 23;7(12):e30424. doi: 10.2196/30424.
8
Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana.
Vaccine. 2023 Mar 24;41(13):2113-2119. doi: 10.1016/j.vaccine.2023.02.024. Epub 2023 Feb 13.
9
COVID-19 Vaccine Acceptance and Uptake in Bangkok, Thailand: Cross-sectional Online Survey.
JMIR Public Health Surveill. 2023 Apr 13;9:e40186. doi: 10.2196/40186.
10
Qatar Healthcare Workers' COVID-19 Vaccine Hesitancy and Attitudes: A National Cross-Sectional Survey.
Front Public Health. 2021 Aug 25;9:727748. doi: 10.3389/fpubh.2021.727748. eCollection 2021.

本文引用的文献

1
The correlates and dynamics of COVID-19 vaccine-specific hesitancy.
Vaccine. 2022 Mar 18;40(13):2020-2027. doi: 10.1016/j.vaccine.2022.02.033. Epub 2022 Feb 17.
5
Vaccine hesitancy in the era of COVID-19.
Public Health. 2021 May;194:245-251. doi: 10.1016/j.puhe.2021.02.025. Epub 2021 Mar 4.
7
Public opinion on global rollout of COVID-19 vaccines.
Nat Med. 2021 Jun;27(6):935-936. doi: 10.1038/s41591-021-01322-9.
8
Vaccine Hesitancy: A Growing Concern.
Paediatr Drugs. 2020 Apr;22(2):105-111. doi: 10.1007/s40272-020-00385-4.
9
Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network.
PLoS One. 2016 Jun 3;11(6):e0156118. doi: 10.1371/journal.pone.0156118. eCollection 2016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验